Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04692116
What this trial is testing

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage

Who this might be right for
Parkinson Disease
Fundación de investigación HM 12
Early research (Phase 1)Study completedNCT02267434
What this trial is testing

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseNeurodegenerative Diseases
Affiris AG 36
Post-approval studies (Phase 4)Ended earlyNCT01048229
What this trial is testing

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
Qualissima 112
Testing effectiveness (Phase 2)UnknownNCT01560754
What this trial is testing

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
James BOYD MD 160
Not applicableActive Not RecruitingNCT06846658
What this trial is testing

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

Who this might be right for
Parkinson DiseaseMSA - Multiple System AtrophyLewy Body Dementia (LBD)+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 180
Post-approval studies (Phase 4)Study completedNCT00125567
What this trial is testing

Stalevo in Early Wearing-Off Patients

Who this might be right for
Idiopathic Parkinson's Disease
Orion Corporation, Orion Pharma 223
Testing effectiveness (Phase 2)Ended earlyNCT03655236
What this trial is testing

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Who this might be right for
Early Parkinson Disease
Sun Pharma Advanced Research Company Limited 513
Testing effectiveness (Phase 2)Study completedNCT00063193
What this trial is testing

National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial

Who this might be right for
Parkinson's Disease
University of Rochester 195
Not applicableStudy completedNCT02511015
What this trial is testing

Hereditary Parkinson s Disease Natural History Protocol

Who this might be right for
Parkinson Disease 6, Early-OnsetParkinson Disease (Autosomal Recessive, Early Onset) 7, HumanParkinson Disease Autosomal Recessive, Early Onset+1 more
National Heart, Lung, and Blood Institute (NHLBI) 31
Not applicableStudy completedNCT05308238
What this trial is testing

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

Who this might be right for
Parkinson Disease
San Jose State University 50
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Post-approval studies (Phase 4)Study completedNCT01485172
What this trial is testing

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 186
Not applicableUnknownNCT01338662
What this trial is testing

Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

Who this might be right for
Parkinson's Disease
Seoul National University Hospital 500
Post-approval studies (Phase 4)Study completedNCT01049984
What this trial is testing

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Teva Neuroscience, Inc. 328
Testing effectiveness (Phase 2)Study completedNCT06596005
What this trial is testing

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 149
Not applicableStudy completedNCT03384797
What this trial is testing

Blood Biomarker in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Duke University 65
Early research (Phase 1)Looking for participantsNCT07064005
What this trial is testing

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Who this might be right for
Parkinsons Disease (PD)
Pravat Mandal 12
Not applicableEnded earlyNCT00261781
What this trial is testing

Walking Capacity in Parkinson's Disease (PD-Walk)

Who this might be right for
Idiopathic Parkinson's Disease
Natalie Allen 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06175767
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Mthera Pharma Co., Ltd. 120
Large-scale testing (Phase 3)Ended earlyNCT01014858
What this trial is testing

Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newcastle-upon-Tyne Hospitals NHS Trust 64
Next Page